Back

Integrating combined inspiratory and expiratory muscle training into hybrid cardiac rehabilitation after cardiac surgery: a randomized controlled trial

23 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Exercise-based cardiac rehabilitation Secondary Prevention EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Busra Ulker Eksi

Istanbul Galata University, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Community-based tele-rehabilitation through elderly congregation facilities improves exercise tolerance and physical performance in older adults: a cluster-assigned controlled study
Mr Y. Tamura (Tochigi, JP)
Abstract Slides
Presentation thumbnail
Which approach to exercise intensity prescription provides better outcomes of cardiac rehabilitation - percentage of heart rate reserve or ventilatory thresholds?
Doctor M. Kurpaska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Comparative effects of different strength training modalities in cardiac rehabilitation: preliminary results
Doctor M. Lamotte (Brussels, BE)
Abstract Slides
Presentation thumbnail
Fruit and vegetable intake and its relationship with the sociodemographic characteristics of patients enrolled in exercise-based cardiovascular rehabilitation
Mr M. Mistura (Ottawa, CA)
Abstract Slides
Presentation thumbnail
Trends in mental health and behavioural risk factors of patients in exercise-based cardiac rehabilitation over 25 years: a retrospective cohort study
Doctor A. Marques Vieira (Ottawa, CA)
Abstract Slides

Access the full session

Session thumbnail
Exercise-based cardiac rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources